Detalhe da pesquisa
1.
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study.
Clin Infect Dis
; 70(11): 2369-2376, 2020 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31300820
2.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
BMC Infect Dis
; 17(1): 420, 2017 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28610605
3.
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study.
Int J Drug Policy
; 62: 14-23, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30352330
4.
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Lancet Gastroenterol Hepatol
; 3(3): 153-161, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310928
5.
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study.
Int J Drug Policy
; 47: 230-238, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28633998
6.
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
Int J Drug Policy
; 47: 177-186, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28624134